New observations on the utility of CA19-9 as a biomarker in Lewis negative patients with pancreatic cancerGuopei Luo, Xianjun Yu, Qiuyi Huang et al.|Pancreatology|2018Cited by 79
The combination of systemic inflammation-based marker NLR and circulating regulatory T cells predicts the prognosis of resectable pancreatic cancer patientsCheng He, Chen Liu, Guopei Luo et al.|Pancreatology|2016Cited by 65
Human profilin 1 is a negative regulator of CTL mediated cell‐killing and migrationRouven Schoppmeyer, Bin Qu, Renping Zhao et al.|European Journal of Immunology|2017Cited by 50
Epithelial–mesenchymal transition in pancreatic cancer: Is it a clinically significant factor?Jia-Hao Jiang, Xianjun Yu, Chen Liu et al.|Biochimica et Biophysica Acta (BBA) - Reviews on Cancer|2014Cited by 42